Pain
News
91% who overdose on opioids continue to receive opioid prescriptions
Key clinical point: Almost all patients treated at EDs for nonfatal opioid overdose continue to receive opioid prescriptions. Major finding: 2,597...
News
Second dose of herpes zoster vaccine beneficial to seniors
Individuals approaching 70 years of age should consider a herpes zoster booster shot to maintain cellular immunity at later stages of life.
News
2014 sets U.S. record for drug overdose deaths
Key clinical point: Efforts to encourage safer prescribing of opioid pain relievers should be strengthened. Major finding: In 2014, opioids were...
News
Review: Opioid prescriptions are the work of many physicians
Contrary to reports that a relative few physicians prescribe most opioids, many primary care providers and specialists prescribe such painkillers...
Conference Coverage
Functional dependence linked to risk of complications after spine surgery
Functional dependence following elective cervical spine procedures was associated with a significantly increased risk of almost all 30-day...
News
Memantine reduces frequency of migraine without aura
Key clinical point: Memantine may help reduce the frequency of migraines without aura. Major finding: Treatment with memantine was associated with...
Conference Coverage
FDA advisory committees support changing codeine contraindications for children
The FDA’s Pulmonary-Allergy Drugs and Drug Safety and Risk Management Advisory Committees voted strongly in favor of amending codeine’s current...
Conference Coverage
PROMIS physical function domain outperforms in cervical spine patients
In elective cervical spine surgery, the PROMIS physical function domain outperformed other commonly used tools to measure patient-reported...
News
More time in front of screens linked to more migraines in young adults
Adolescents and young adults who spend more time in front of computer, tablet, television, and smartphone screens experience an uptick in...
Conference Coverage
AHA: DAPT prevents migraines after atrial-septal defect closure
Key clinical point: Three months of dual antiplatelet therapy surpassed aspirin monotherapy for preventing new-onset migraine headaches following...
News
FDA approves first naloxone nasal spray for opioid overdose
The Food and Drug Administration has approved Narcan, a naloxone nasal spray used to stop or reverse the effects of opioid overuse.